thrombin receptor peptide sfllrnp has been researched along with thromboxane a2 in 3 studies
Studies (thrombin receptor peptide sfllrnp) | Trials (thrombin receptor peptide sfllrnp) | Recent Studies (post-2010) (thrombin receptor peptide sfllrnp) | Studies (thromboxane a2) | Trials (thromboxane a2) | Recent Studies (post-2010) (thromboxane a2) |
---|---|---|---|---|---|
92 | 10 | 29 | 5,617 | 224 | 429 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tesfamariam, B | 1 |
Derkach, DN; Hirano, K; Ihara, E; Kanaide, H; Nishimura, J; Takahashi, S | 1 |
Cox, D; Fitzgerald, DJ | 1 |
3 other study(ies) available for thrombin receptor peptide sfllrnp and thromboxane a2
Article | Year |
---|---|
Thrombin receptor-mediated vascular relaxation differentiated by a receptor antagonist and desensitization.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amino Acid Sequence; Animals; Bradykinin; Coronary Vessels; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Kinetics; Molecular Sequence Data; Muscle Relaxation; Muscle, Smooth, Vascular; Oligopeptides; Peptide Fragments; Prostaglandin Endoperoxides, Synthetic; Receptors, Thrombin; Serotonin; Substance P; Swine; Thrombin; Thromboxane A2; Vasoconstrictor Agents | 1994 |
Thrombin causes endothelium-dependent biphasic regulation of vascular tone in the porcine renal interlobar artery.
Topics: Animals; Biological Factors; Calcium; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Methacrylates; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Phenylephrine; Potassium; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2; Renal Artery; Swine; Thrombin; Thromboxane A2; Thromboxane-A Synthase; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2000 |
Lack of Bioequivalence Among Low-dose, Enteric-coated Aspirin Preparations.
Topics: Arachidonic Acid; Aspirin; Dose-Response Relationship, Drug; Humans; Peptide Fragments; Platelet Aggregation Inhibitors; Tablets, Enteric-Coated; Therapeutic Equivalency; Thromboxane A2 | 2018 |